SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-222493
Filing Date
2020-08-17
Accepted
2020-08-17 16:45:55
Documents
13
Period of Report
2020-08-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d28349d8k.htm   iXBRL 8-K 27373
2 EX-99.1 d28349dex991.htm EX-99.1 19847
  Complete submission text file 0001193125-20-222493.txt   177551

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ubx-20200817.xsd EX-101.SCH 3085
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20200817_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20200817_pre.xml EX-101.PRE 11416
6 EXTRACTED XBRL INSTANCE DOCUMENT d28349d8k_htm.xml XML 3363
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 201110805
SIC: 2834 Pharmaceutical Preparations